EcoDrugPlus

Melanocortin 4 Receptor

Ensembl ID : ENSBMUG00000017101
Gene Symbol: MC4R
3 Cross references
229 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSBMUG00000005597
Gene Symbol: MTNR1A
3 Cross references
216 Possible Orthologues:

Melatonin Receptor 1b

Ensembl ID : ENSBMUG00000017049
Gene Symbol: MTNR1B
3 Cross references
107 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSBMUG00000012160
Gene Symbol: MME
3 Cross references
234 Possible Orthologues:

Membrane Primary Amine Oxidase

Ensembl ID : ENSBMUG00000014916
Gene Symbol: LOC102273246
2 Cross references
304 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSBMUG00000020530
Gene Symbol: METAP2
3 Cross references
230 Possible Orthologues:

Microtubule Associated Protein Tau

Ensembl ID : ENSBMUG00000025072
Gene Symbol: MAPT
3 Cross references
226 Possible Orthologues:

Mineralocorticoid Receptor

Ensembl ID : ENSBMUG00000025653
Gene Symbol: LOC102264425
2 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSBMUG00000002807
Gene Symbol: MAPK1
1 Cross references
214 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSBMUG00000021832
Gene Symbol: MAPK10
1 Cross references
222 Possible Orthologues:

Mitogen-Activated Protein Kinase 11

Ensembl ID : ENSBMUG00000015766
Gene Symbol: MAPK11
3 Cross references
201 Possible Orthologues:

Mitogen-Activated Protein Kinase 14

Ensembl ID : ENSBMUG00000013192
Gene Symbol: MAPK14
3 Cross references
294 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).